Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation

This publication has 172 references indexed in Scilit:

• Peptides derived from the whole sequence of BCR‐ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes
  European Journal of Immunology, 1997
• Restoration of T and NK cell function in GM-CSF mobilized stem cell products from breast cancer patients by monocyte depletion
  Bone Marrow Transplantation, 1997
• Subcutaneous versus intravenous low-dose IL-2 therapy after autologous transplantation: results of a prospective, non-randomized study
  Bone Marrow Transplantation, 1997
• The treatment of relapsed or refractory intermediate grade non-Hodgkin’s lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon
  Bone Marrow Transplantation, 1997
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995
• Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction
  European Journal of Immunology, 1995
• Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach.
  Journal of Clinical Investigation, 1994
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• Designed transfer of specific immune responses with bone marrow transplantation.
  Journal of Clinical Investigation, 1986
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985